The ester-linked ω-hydroxy acyl chain linked to a sphingosine base referred to as CER EOS is essential for the skin barrier lipid organization. While the majority of the skin lipids form a dense, crystalline structure, associated with low permeability, the unsaturated moiety of CER EOS, (either the linoleate or the oleate chain) exists in a liquid phase at the skin's physiological temperature. selleck chemicals Thus, the relationship between CER EOS and barrier function is not entirely comprehended. We studied the permeability and lipid organization in skin lipid models, gradually increasing in CER EOS concentration, mixed with non-hydroxy sphingosine-based ceramide (CER NS) in an equimolar ratio of CERs, cholesterol, and free fatty acids (FFAs) mimicking the ratio in the native skin. A significant increase in the orthorhombic-hexagonal phase transition temperature was recorded when CER EOS concentration was raised to 70 mol% of the total CER content and higher, rendering a higher fraction of lipids in the orthorhombic phase at the expense of the hexagonal phase at physiological temperature. The model's permeability did not differ when CER EOS concentration ranged between 10 and 30% but increased significantly at 70% and higher. Using CER EOS with a perdeuterated oleate chain, it was shown that the fraction of lipids in a liquid phase increased with CER EOS concentration, while the neighboring CERs and FFAs remained in a crystalline state. The increased fraction of the liquid phase therefore, had a stronger effect on permeability than the increased fraction of lipids forming an orthorhombic phase.Duchenne muscular dystrophy (DMD) is caused by a mutation of the muscle membrane protein dystrophin and characterized by severe degeneration of myofibers, progressive muscle wasting, loss of mobility, and, ultimately, cardiorespiratory failure and premature death. Currently there is no cure for DMD. Herein, we report that skeletal muscle-specific knockout (KO) of the phosphatase and tensin homolog (Pten) gene in an animal model of DMD (mdx mice) alleviates myofiber degeneration and restores muscle function without increasing tumor incidence. Specifically, Pten KO normalizes myofiber size and prevents muscular atrophy, and it improves grip strength and exercise performance in mdx mice. Pten KO also reduces fibrosis and inflammation, and it ameliorates muscle pathology in mdx mice. Unbiased RNA sequencing reveals that Pten KO upregulates extracellular matrix and basement membrane components positively correlated with wound healing and suppresses negative regulators of wound healing and lipid biosynthesis, thus improving the integrity of muscle basement membrane at the ultrastructural level. Importantly, pharmacological inhibition of PTEN similarly ameliorates muscle pathology and improves muscle integrity and function in mdx mice. Our findings provide evidence that PTEN inhibition may represent a potential therapeutic strategy to restore muscle function in DMD. In the United Kingdom National Health Service, finite resources make the adoption of minimally invasive mitral valve surgery challenging unless greater operative costs (vs sternotomy) are balanced by post-operative savings. We examined whether the cost analysis now became unfavourable. All patients (n=380) undergoing isolated mitral valve surgery ± maze over a 3-year period via either minimally invasive (MI) or sternotomy approaches (ST) were included. Propensity matching (two 11 matched cohorts, n=75 per group) and multivariable regression were used to assess for the effect on cost. Cost data were prospectively collected from Service Line Reporting and reported in Sterling (£) as median (IQR). Matched data revealed total hospital costs were equivalent (MI vs ST, £16672 (15044, 20611) vs £15875 (12281, 20687), p=0.33). Three of 15 costing pools were significantly different operative costs were higher for the MI group (MI vs ST, £7458 (6738, 8286) vs £5596 (4204, 6992), p<0.001) while ward costs (boarding, nursing) (MI vs ST, £1464 (1146, 1864) vs £1733 (1403, 2445), p=0.006), and pharmacy services (MI vs ST, £187 (140, 239) vs £244 (179, 375), p<0.001) were lower for the MI group. Hospital stay was shorter in the MI group (MI vs ST, 6 days (5, 8) vs 8 days (6, 11), p<0.001). Multivariable regression produced similar findings. There was no difference in overall hospital cost between MI and ST mitral valve surgery higher operative costs of MI surgery were offset by lower post-operative costs, with a 2-day shorter hospital stay.There was no difference in overall hospital cost between MI and ST mitral valve surgery higher operative costs of MI surgery were offset by lower post-operative costs, with a 2-day shorter hospital stay. In stage III-IVa thymic epithelial tumors (TETs), infiltration of superior vena cava (SVC) is not rare. The extent of SVC resection depends on the width of the area of neoplastic invasion. Our paper aims to evaluate the safety and long-term outcomes of extended thymectomy for TETs with SVC resection compared with advanced-stage TETs patients without SVC resection. Retrospective review of the experience on patients who underwent extended thymectomy for TETs in the last twenty years, according to STROBE methodology. Progression-free survival (PFS) and overall survival (OS) were calculated using the Kaplan-Meier method. A backward stepwise Cox regression multivariate analysis was performed to determine factors associated with long-term outcomes. 78 patients underwent surgery for advanced-stage TETs (Masaoka-Koga stages III-IVa) from January 1998 to April 2019. 14 (17.9%) underwent thymectomy with resection of SVC. Presence of a thymic carcinoma (HR=2.26; 95% CI=1.82-6.18; p=0.038) and the SVC resection (HR=1.89; 95% CI=1.11-3.96; p=0.041) were adverse prognostic factors at multivariate analysis. The median OS and the PFS of all SVC resected patients were 50 (range 5-207) and 31 months (range 5-151), respectively. There was no significant difference in OS (p=0.28) and PFS (p=0.32) between SVC resected and not resected patients. SVC resection is a safe and effective procedure to restore the venous system continuity and does not seem to affect survival and disease recurrence. This surgical approach allows radical resection of locally advanced TETs, even after neoadjuvant chemotherapy.SVC resection is a safe and effective procedure to restore the venous system continuity and does not seem to affect survival and disease recurrence. This surgical approach allows radical resection of locally advanced TETs, even after neoadjuvant chemotherapy.